Probiotics reduce VAP

In this trial of intubated patients at high risk for VAP, those randomized to enteral lactobacillus BID had a significantly lower rate of VAP (and Cdiff). Use of lactobacillus reduces VAP and Cdiff in intubated patients (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment